| Secondary |
| Drug Use For Unknown Indication |
24.4% |
| Ill-defined Disorder |
24.4% |
| Analgesic Therapy |
12.8% |
| Arthritis |
6.4% |
| Product Used For Unknown Indication |
6.4% |
| Procedural Pain |
5.1% |
| Fungal Infection |
3.8% |
| Type 2 Diabetes Mellitus |
3.8% |
| Blood Pressure Abnormal |
2.6% |
| Deep Vein Thrombosis |
2.6% |
| Candidiasis |
1.3% |
| Ocular Hyperaemia |
1.3% |
| Open Angle Glaucoma |
1.3% |
| Osteoporosis |
1.3% |
| Prophylaxis |
1.3% |
| Smoking Cessation Therapy |
1.3% |
|
| Weight Decreased |
15.4% |
| Creutzfeldt-jakob Disease |
11.5% |
| Post Procedural Haemorrhage |
11.5% |
| Drug Interaction |
7.7% |
| International Normalised Ratio Increased |
7.7% |
| Visual Disturbance |
7.7% |
| Drug Ineffective |
3.8% |
| Eye Irritation |
3.8% |
| Paranoia |
3.8% |
| Pruritus |
3.8% |
| Rash |
3.8% |
| Terminal Dribbling |
3.8% |
| Ulcer Haemorrhage |
3.8% |
| Vaginal Prolapse |
3.8% |
| Ventricular Tachycardia |
3.8% |
| Vision Blurred |
3.8% |
|
| Concomitant |
| Product Used For Unknown Indication |
36.6% |
| Drug Use For Unknown Indication |
21.5% |
| Hypertension |
7.0% |
| Blood Cholesterol Increased |
3.6% |
| Pain |
3.5% |
| Rheumatoid Arthritis |
3.1% |
| Supplementation Therapy |
2.7% |
| Osteoporosis |
2.7% |
| Renal Failure Chronic |
2.3% |
| Prophylaxis |
2.0% |
| Medical Diet |
2.0% |
| Gastrooesophageal Reflux Disease |
2.0% |
| Diabetes Mellitus |
1.7% |
| Constipation |
1.4% |
| Atrial Fibrillation |
1.4% |
| Depression |
1.4% |
| Vitamin Supplementation |
1.4% |
| Multiple Myeloma |
1.3% |
| Dyspepsia |
1.2% |
| Routine Health Maintenance |
1.1% |
|
| Flushing |
11.7% |
| Weight Decreased |
8.9% |
| Pain |
8.4% |
| Pruritus |
6.3% |
| Fatigue |
5.8% |
| Vomiting |
5.8% |
| Hepatic Enzyme Increased |
5.1% |
| Nausea |
4.6% |
| Pain In Extremity |
4.3% |
| Rash |
4.3% |
| Weight Increased |
4.3% |
| Dyspnoea |
3.8% |
| Paraesthesia |
3.8% |
| Myocardial Infarction |
3.6% |
| Drug Ineffective |
3.3% |
| Pyrexia |
3.3% |
| Somnolence |
3.3% |
| Vision Blurred |
3.3% |
| Palpitations |
3.0% |
| Visual Impairment |
3.0% |
|
| Interacting |
| Drug Use For Unknown Indication |
66.7% |
| Hiv Infection |
14.8% |
| Analgesic Therapy |
7.4% |
| Acute Myeloid Leukaemia |
3.7% |
| Chronic Myeloid Leukaemia |
3.7% |
| Thrombosis Prophylaxis |
3.7% |
|
| Gastrointestinal Haemorrhage |
20.0% |
| Haemorrhage Intracranial |
20.0% |
| Epistaxis |
10.0% |
| International Normalised Ratio Decreased |
10.0% |
| Neutropenia |
10.0% |
| Post Procedural Haemorrhage |
10.0% |
| Vasodilatation |
10.0% |
| Virologic Failure |
10.0% |
|
